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Summary 
Mice with homologous disruption of the gene coding for the ligand-binding chain of the interferon 
(IFN) 3' receptor and derived from a strain genetically resistant to infection with Leishmania 
major have been used to study further the role of this cytokine in the differentiation of functional 
CD4 + T cell subsets in vivo and resistance to infection. Wild-type 129/Sv/Ev mice are resistant 
to infection with this parasite, developing only small lesions, which resolve spontaneously within 
6 wk. In contrast, mice lacking the IFN-3, receptor develop large, progressing  lesions. After 
infection,  lymph nodes (LN) and spleens from both wild-type and knockout mice showed an 
expansion of CD4 § cells producing IFN-3, as revealed by measuring IFN-3, in supernatants of 
specifically stimulated  CD4 +  T  cells, by  enumerating  IFN-3,-producing  T  cells, and  by 
Northern blot analysis of IFN-v transcripts. No biologically active interleukin (IL) 4 was detected 
in supernatants  of in vitro-stimulated LN or spleen cells from infected wild-type or deficient 
mice. Reverse  transcription polymerase chain reaction analysis with primers specific  for IL-4 showed 
similar IL-4 message levels in LN from both types of mice. The IL-4 message levels observed 
were comparable to those found in similarly infected C57BL/6 mice and significantly lower than 
the levels found in BALB/c mice. Anti-IFN-3" treatment of both types of mice failed to alter 
the pattern of cytokines produced after infection. These data show that even in the absence of 
IFN-v receptors, T helper cell (Th) 1-type responses still develop in genetically resistant mice 
with no evidence for the expansion of Th2 cells. 
I 
nfection of mice with the protozoan parasite Leishmania 
major has been used as a model system for the study of 
the effector functions of IFN-3, and other lymphokines against 
intracellular  microorganisms.  Several findings have already 
dearly demonstrated the importance of IFN-'y for the elimi- 
nation of  L. major  by infected  hosts. Results from several  labora- 
tories have documented that, when treated with anti-IFN-'y 
neutralizing antibodies, mice normally resistant to infection 
with L. major are not able to control this infection (1, 2). 
In addition, the destruction ofintracellular leishmania by mu- 
fine macrophages was shown to result from the IFN-y-in- 
duced production of nitric oxide (NO) by these cells (3, 4). 
After infection of mice from various inbred  strains with 
L. major, the parasite burden and the resulting pattern of dis- 
ease correlates with the expansion of CD4 + T cells from a 
particular  functional subset.  Resistance  to infection  with 
L. major, which characterizes mice from several  inbred strains 
(CBA, C57BL/6, etc.) has been shown to correlate with the 
selective triggering of a Thl  CD4 + T  cell response and 
results at least in part from the activity of these cells. In con- 
trast,  the susceptibility  of BALB/c mice results  from the 
preferential expansion and activity of Th2-type T cells (5, 6). 
Thus, the mouse model of infection with L. major has been 
instrumental in the elucidation of some of the mechanisms 
controlling the development of polarized Thl versus Th2 re- 
sponses during antigenic stimulation. In this context, studies 
have already underlined the importance that cytokines, present 
at the early stage of infection with L. major, could have on 
the differentiation of CD4 + T cell precursors toward one or 
the other functional phenotype. Administration of anti-IFN-3, 
mAb to genetically resistant mice was shown to interfere with 
the development of a Thl-type response and to promote the 
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ment of susceptible BALB/c mice with anti-IL-4 mAbs at 
an early stage of infection hampers the expansion of Th2 cells, 
allowing the development of a Thl-type response (8).  Ad- 
ministration of exogenous IFN-y at the initiation of infec- 
tion transiently reversed the Th2-type response normally dis- 
played by T lymphocytes from susceptible mice (7). Similarly, 
the injection of recombinant IL-4 to resistant mice at the time 
of infection led to the transient development of a Th2-type 
response (9). Taken together, these data indicate that IFN-3, 
and IL-4 play a pivotal role in the development of polarized 
Thl and Th2 responses, respectively, in this model of infec- 
tion. The role of IL-4 in the generation of a Th2-type re- 
sponse is also  supported by several observations made both 
in vitro and in vivo in mitogen- or nominal antigen-driven 
responses (10-13). However, the data concerning the impor- 
tance of IFN-3' in promoting the expansion of Thl cells and 
inhibiting the development of Th2-type response are  still 
conflicting (10,  12-15). 
Recently, transgenic mice that lack the IFN-~/R have been 
produced,  offering the possibility to elucidate further the 
effector and the regulatory functions of IFN-y (16). In this 
study, we investigated the course of disease and the functional 
characteristics of the CD4 + T cell responses triggered after 
infection with L. major of mice from a genetically resistant 
background lacking the IFN-qrR. 
Materials and Methods 
Mice.  129/Sv/Ev mice of either sex homozygous for disrupted 
IFN-3'R gene (IFN-3"R  -/-) and for null mutation (IFN-3,R +/+) 
were produced as described (16) and maintained under pathogen- 
flee conditions until use at 6-10 wk of age. BALB/c and C57BL/6 
mice of the same age (IFFA Credo, Saint-Germain-sur-l'Abresle, 
France) were used in some experiments. 
Parasites  and Infection of  Mic~  L. major  LV 39 (MRHO/SU/59/P- 
strain) were maintained in vivo and grown in vitro as described 
(17). Mice were infected subcutaneously into one hind foot pad 
with 2  x  106 L. major stationary-phase promastigotes in a final 
volume of 50 #1. The development of lesions was monitored by 
measuring, with a vernier caliper, the increase in foot pad thick- 
ness compared  with the uninfected  controlateral  foot pad. At selected 
times, the number of viable parasites in infected tissues was also 
measured by use of a parasite-limiting dilution assay previously de- 
scribed (18). In some experiments, mice were treated intraperito- 
neally with 2 mg XMG 1.2 anti-IFN-3~ mAb (19) 2 d before infec- 
tion and with 320 #g of mAb weekly for 3 wk after infection. 
Lymphocyte Cultures.  LN and spleen  cell suspensions were stimu- 
lated, at the indicated cell numbers, with 4  x  106 UV-irradiated 
L. major promastigotes in a final volume of 1 ml at 37~  and an 
atmosphere  of 7%  COz.  Cells were cultured  in DMEM  sup- 
plemented with 5% heat-inactivated  FCS, t-glutamine (216 rag/m1), 
5  x  10-s M 2-ME, and 10 mM Hepes. Culture supernatants were 
collected after 18-72 h of stimulation and stored at  -20~  until 
use. Similar experiments  were also carried out with  CD4 + T 
cell-depleted populations. Depletion  of CD4 + cells was accom- 
plished by treatment of 5  x  107 cells with an anti-CD4 IgM mAb 
(RL-172.4 [20], a gift of H. R. MacDonald, Ludwig Institute for 
Cancer Research, Epalinges, Switzerland) and rabbit complement 
(Low-Tox; Cederlane, Horuby,  Canada). 
Detection of lFN-'y and IL4 in Culture Supernatant.  IFN-3' was 
measured by ELISA as previously  described (21). Ib4 was measured 
by a bioassay using the CT.4S cell line as described (22). Recom- 
binant mouse IFN-3' expressed in L1210  calls (gift of Y. Watanabe, 
Kyoto University, Kyoto, Japan) and recombinant mouse II.-4 ex- 
pressed in X63Ag-653 ceils (gift of E  Melchers, Basel Institute 
of Immunology, Basel, Switzerland) were used as standards. The 
limit of detection of these assays was 10 U/m1 for IFN-qr and 0.3 
ng/ml for IL-4. 
Enumeration of lFN-7-ywducing  Cells.  Cells  producing IFN-3~ 
were enumerated by use of a modification of an ELISPOT assay 
previously reported  (23). Briefly, 96-well flat-bottom  microtiter 
plates (Nunc, Roskilde, Denmark) were coated with purified anti- 
IFN-'y mAb  R4-6A2  (24) (5 gg/ml) and incubated at 4~  for 
14-16 h. Free binding sites were blocked with PBS containing 1% 
BSA for 2 h at 37~  Wells were washed three times with sterile 
PBS containing 0.5% Tween-20. Serial twofold dilutions of lym- 
phocyte suspensions (100 gl/well) from spleen or LN cell  cultures 
that had been stimulated in vitro with L.  major for 18 h were 
then added and incubated for 4 h. After three washes, biotinylated 
anti-IFN-3~ mAb AN 18.17.24 (gift of S. Landolfo, University of 
Turin, Turin, Italy) diluted in PBS containing 1% BSA, was added 
(2.5 #g/m1). After 14 h of incubation at 4~  plates were washed 
three times before the addition of alkaline phosphatase-steptavidin 
conjugate (diluted 1:1,000 in PBS) and further incubated for 2 h 
at 37~  before washing and the addition of substrate. The sub- 
strate, consisting of 5-bromo-4-chloro-3-indolyl  phosphate (BCIP), 
diluted in 2-amino-2-methyl-l-propanol (AMP) (both from Sigma, 
Buchs, Switzerland) buffer, was incubated at 37~  for 45 rain be- 
fore addition to wells. After 2 h of incubation with the substrate, 
the blue spots were counted by use of an inverted microscope. 
Treatment of LN Cells with Recombinant IFN-  7 and Flow Cytom- 
etry.  LN cells from IFN-3~R  -/- and IFN-yR §  mice were cul- 
tured in vitro (4  x  106 cells/ml) in the presence or absence of 
50-1,000 U/ml recombinant mouse IFN-y (Genentech, South San 
Francisco, CA). After 24, 48, or 72 h, cells were harvested, washed 
with PBS containing 5% FCS, and assayed by flow cytometry for 
the expression  of the IFN-~/-inducible  Ly6A/E surface  marker (25). 
Staining was performed with 0.25 #g FITC-conjugated rat IgG2a 
anti-Ly6A/E  mAb D7 (26) (Pharmingen, Lugano, Switzerland) 
in the presence of I gg rat IgG2b anti-mouse Fc~/RII mAb 24G2 
(kind gift of  Dr. H. R. MacDonald) to inhibit nonspecific  binding 
of Abs to the Fc~/RII. Analysis of stained ceils was performed by 
use ofa FACScan  |  (Becton Dickinson & Co., Mountain View, CA). 
Northern Blot Analysis.  Total  RNA was isolated from spleen 
and LN cell populations  depleted or not of CD4 + cells. After 
washing in PBS, cells were resuspended in guanidine thiocyanate 
denaturing solution (4 M GCN, 0.75 M sodium citrate, 0.5% sar- 
kosyl, 0.1 M B-ME). The mixture was acidified with one-tenth 
volume 2 M sodium acetate, pH 4.5, and extracted with phenol- 
chloroform.  After precipitation with one-tenth vol 7.5 M NH~ 
acetate and 2 vol ethanol, the RNA was resuspended in water. 5 
/~g total RNA was denatured at 65~  in sample buffer (50% for- 
mamide, 0.66 M formaldehyde,  0.02 M 3-[N-morpholino] propane- 
sulfonic acid [MOPS], 5 mM sodium acetate, I mM EDTA, 0.5% 
glycerol). 1 gl of I mg/ml ethidium bromide was added to each 
sample before electrophoresis  through a 1.1% agarose gel containing 
0.66 M formaldehyde, 0.02 M MOPS, 5 mM sodium acetate, and 
1 mM EDTA. RNA was transferred to a membrane (Hybond; 
Amersham, Bucks, UK) by capillary action, and RNA was fixed 
to the membrane by use of a UV Stratalinker (Stratagene Inc., La 
Jolla, CA). Filters were prehybridized in 50% formamide, 5 x SSC, 
2x Denhardt's solution (0.04% Ficoll 400, 0.04% polyvinyl pyr- 
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salmon sperm DNA, and 0.5 mg/ml yeast tRNA at 65~  for 4 h 
before addition of the probe. Antisense RNA probes specific for 
IFN-7 or II,-4 (27, 28) were generated by use of SP6 RNA poly- 
merase. Transcripts were treated with DNase and unincorporated 
nucleotides removed by passage over a TE (10 mM Tris, 1 mM 
EDTA)-equilibrated Sephadex G-75 column (Pharmacia, Uppsala, 
Sweden). After overnight  hybridization  at 65~  filters  were washed 
four times for 30 rain with 0.1x  SSC, 0.1% SDS, at 65~ 
PCR Analysis.  First-strand cDNA synthesis  was preformed on 
1/~g total RNA by use of a first-strand cDNA kit (Pharmacia). 
PCR was performed directly on the first-strand cDNA by use of 
Taq DNA polymerase (Boehringer Mannheim, Mannheim, Ger- 
many) according  to the manufacturers  specifications  with II.-4- and 
GAPDH-specific primers described previously (29). The level of 
IL-4 message was normalized between samples with the level of 
GAPDH message used as a control. 
l~sults 
Development of Lesions Induced by L. major in IFN-9,R -~- 
and IFN-'gR +/+  Mice.  IFN-'yR  -/-  mice  and  syngeneic 
control mice (IFN-TR +/+) were infected with L. major sub- 
cutaneously in one hind footpad, and the development of le- 
sions was monitored for 40 d. In Fig. 1, representative results 
from  one  of three  experiments  show  that  control  IFN- 
7R +/§  mice were resistant to infection since only small le- 
sions developed and then resolved spontaneously within 40 d. 
In contrast,  the IFN-TR-/-  mice developed large lesions, 
which were still progressing at the time of killing. Estima- 
tion by a limiting dilution assay of the numbers of parasites 
in lesions  40 d after infection showed a 15-fold increase in 
the number of L.  major in foot pads of IFN-q,R-/-  mice. 
Additionally, LN draining the site of lesions and spleens of 
IFN-TR-/- mice contained significantly higher numbers of 
parasites  compared with IFN-TR +/+  mice (Table  1).  It is 
noteworthy that for the first 20 d of infection, the numbers 
of parasites found in lesions and lymphoid organs were similar 
in  IFN-TR +/+  and IFN-TR -/-  mice (data  not shown). 
These results confirm the crucial role of IFN-7 in the elimi- 
nation of L.  major by infected hosts. 
Functional Characteristics of the CD4 + T  Cells Triggered in 
IFN-9"R-/-  Mice Infected with L. major.  The susceptibility 
of BALB/c mice to infection with L. major has clearly been 
related to the expansion of Th2-type cells, whereas resistant 
mice developed a Thl-type response (5). Since IFN-3' has been 
shown to inhibit the proliferation of Th2 cells and favor the 
differentiation of T cell precursors  toward a Thl phenotype 
(30), we assessed whether L. major infection of IFN-TR-/- 
mice,  derived from a strain resistant to infection with this 
parasite,  would lead to a polarized Th2 response. 
To this end, the production of IFN-7 and IL-4 by spleen 
and LN cells obtained from IFN-~R-/-  and IFN-yR+/.  + 
mice at various times after infection with L. major was mea- 
sured after stimulation in vitro with UV-irradiated parasites 
as a source of specific antigen. Results from a representative 
experiment show that, during the first 20 d of infection, the 
production of IFN-T by specifically stimulated LN and spleen 
cells was comparable in both IFN-TR- / -  and IFN-TR +  / + 
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Figure 1.  Course  of L. major  infection  in IFN-3,R  -/- and IFN-TR  +/+ 
mice. Mice (eight per  group) were infected by injecting 3  x  106 
stationary-phase  parasites subcutaneously  into the left  hind  foot  pad. Foot 
pad swelling  was monitored  by use of a caliper, and lesion size was deter- 
mined by subtracting  the thickness of the uninfected  foot pad from the 
thickness of the infected  foot pad. The mean and SEM are shown from 
one of three experiments that gave similar results. 
mice (Table 2).  On day 40, significantly larger amounts of 
IFN-7 were produced by both LN and spleen cells from IFN- 
3,R-/-  mice.  The IFN-T was produced by CD4 + T  cells 
since depletion of these T  cells from both LN and spleen 
cell populations abrogated the production of IFN-7 upon 
specific stimulation (Table 2). 
The release of high amounts of IFN-7 by specifically  stimu- 
lated CD4 + T  cells from IFN-TR-/-  mice 40 d after in- 
fection could not only be the result of an increased frequency 
of these cells, but could also be a consequence of the inability 
of cells from these mice to absorb  some of the IFN-7 pro- 
duced in cultures. Therefore, the number of CD4 § T  cells 
producing IFN-y upon specific stimulation in vitro was com- 
pared in the spleen and draining LN of infected IFN-TR-/- 
and IFN-TR +/+  mice by use of a  quantitative ELISPOT 
assay that allows the detection of individual IFN-T-producing 
Table  1.  Parasite  Load in Lesions and Lymphoid Tissues of Mice 
Lacking IFN-'y  Receptors Infected with L. Major 
Number of parasites 
40 d after infection* 
Organ  IFN-TR-/-  IFN-TR +  / + 
Foot pad (L.  major/footpad)*  107 
LN (L.  major/lO  6 LNC)  s  6  x  iO  s 
Spleen (L.  major/lO  6 SC)  4.1 
4.5  x  10  s 
11 
0.2 
* Data represent the number of viable parasites as determined  by limit- 
ing dilution assay  (18). Results are from one of three experiments that 
gave similar results. 
* Foot pads from two mice were used for these determinations. 
S  LN cells (LNC) or spleen cells (SC) from four to eight mice were used 
for these determinations. 
963  Swihart  et al. Table  2.  IFN-'y Production In  Vitro by Specifically Stimulated Spleen and Lymph Node  Cells from Mice Lacking IFN-  7  Receptors 
after Infection with L.  major 
IFN-3' production (U/ml)  at  different  times  after infection* 
In vitro  Day 12  Day 20 
depletion  with 
Organ  anti-CD4 mAb  _ / _ *  + / + s  /  + / + 
Day 40 
-/-  +/+ 
Spleen  -  nt  nt  17  12  823  36 
+  nt  nt  <10  <10  <10  <10 
LN  -  10  12  28  38  800  64 
+  nt  nt  <10  <10  <10  <10 
* IFN-3t production by cells stimulated in vitro for 4 h with UV irradiated parasites was measured by ELISA as described in Materials and Methods. 
Results are from one of three experiments with  similar results. 
* IFN-3'R-/- mice. 
S IFN-3~R+/+ mice. 
nt, not tested. 
cells.  Compared to similarly infected IFN-'yK  +  / + mice, the 
number of CD4 + T  cells producing IFN-'y in response to 
stimulation with L.  major  in vitro was greatly increased in 
the spleen and draining LN of IFN-',/R-/-  mice 40 d after 
infection (Fig. 2). It is noteworthy that these cells were not 
detectable in noninfected mice (data not shown) and that their 
numbers were similar in IFN-3"K-/- and IFN-3'R +  / + mice 
20 d after infection (Fig. 2). These results show that the in- 
creased  IFN-3r  production  by  CD4 +  T  cells  from  IFN- 
3'R -/-  mice  results  from  an  increased  frequency  of re- 
sponding cells. 
We then investigated whether IFN-3rR-/- mice exhibited 
an expansion of Th2-type CD4 + T  cells after infection with 
L.  major by measuring biologically  active IL-4 in superna- 
rants  of LN  and  spleen  cells  specifically  stimulated  with 
L. major.  Results have consistently shown that IL-4 was not 
detectable (<0.3 ng/ml) in supernatants of specifically stimu- 
lated CD4 + T  cells from both IFN-'yR  -/-  and IFN-yK  +/+ 
mice. Supernatants of similarly stimulated lymphocytes from 
infected genetically susceptible BALB/c mice contained bio- 
logically active IL-4 (<2  ng/ml). 
To evaluate whether  the type of CD4 + T  cell responses 
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Figure 2.  Enumeration  oflFN-3'-producing spleen and 
LN cells from L.  major-infected mice. Total or CD4 + 
depleted cell populations from eight infected mice were 
stimulated in vitro for 18 h with UV-irradiated parasites 
as described in Materials and Methods. Serial twofold di- 
lutions were then tested in duplicate for cells producing 
IFN-y by ELISPOT. Data are presented as the number 
of IFN-~f-producing  calls per 10  s ceils. These results are 
from one of three experiments with similar results. 
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tion in vivo, the RNA isolated from spleen and LN of IFN- 
3,R -/-  and IFN-q,R +/+  mice 20 d  after infection was ex- 
amined for IFN-3' and IL-4 transcripts.  Results presented in 
Fig. 3 show higher levels of IFN-3, mRNA in cells obtained 
from  IFN-q,R-/-  compared  with  IFN-q,R +  / §  mice.  Cell 
populations  depleted of CD4 + T  cells had very low levels 
of IFN-3' mRNA,  indicating  that  CD4 + T  cells  were the 
main  source of IFN-3, in these mice.  It is noteworthy that 
no detectable expression of IFN-3' mRNA was found in ei- 
ther noninfected IFN-'),R-/-  or IFN-'yR +/§  mice (data not 
shown).  A  low level of IL-4 message was present in spleen 
cells from both types of infected mice (Fig.  3), which, how- 
ever did not differ from  the levels  of expression in normal 
uninfected mice (data not shown). Interestingly,  similar low 
Figure  3.  Cytokine  mRNA levels  in draining LN and spleen  cells  from 
mice 20 d after infection with L. major. Total RNA was purified from 
LN and spleen  cells  from infected  mice (eight per group) and was analyzed 
by Northern blot for presence  of  cytokine  messages  by probing with IFN-y- 
or II~4-specific  probes. A photo for the ethidium bromide-stained  gel (Eth 
Br; bottom)  allows  comparison of relative amounts of RNA loaded  in each 
lane. Similar results were obtained in three separate experiments. 
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amounts of IL-4 mRNA were observed in cell populations 
depleted  of CD4 +  T  cells.  Similar  results  were  obtained 
with RNA isolated from mice 40 d after infection (data not 
shown). 
Taken together,  these results show that L. major infection 
leads, in both IFN-q,R -/-  and IFN-q,R +/+  mice, to the ex- 
pansion of Thl-type CD4 + T  cell populations that produce 
IFN-',/without evidence for a concomitant expansion of IL- 
4-producing  Th2-type  CD4 + T  cells. 
Effect  of Treatment of lFN-TR-/-  Mice  with Anti-IFN-~/ 
mA b on the Course Of  L. major Infection and the Functional Char- 
acteristics of the CD4 + T  Cell Response.  Since IFN-'yR-/- 
mice lack the ligand-binding  chain of the IFN-3'R (16),  it 
is highly unlikely that  the Thl-type CD4 + T  cell response 
observed in these mice after L.  major infection is mediated 
through signals delivered by IFN-'y through its receptor. In 
fact, the increased expression of the IFN-q,-inducible Ly6A/E 
marker at the surface of IFN-3'R +  / + LN cells stimulated in 
vitro with recombinant IFN-3, (Fig. 4, right) was never ob- 
served when LN cells  from IFN-q,R-/-  mice were stimu- 
lated in the same manner at doses of IFN-3' as high as 1,000 
U/ml  (Fig.  4,  le~). 
To further rule out the remote possibility that the IFN-3, 
produced in IFN-3,R-/-  mice is driving the differentiation 
of CD4 + T  cell precursors toward a Thl functional pheno- 
type through a pathway not requiring the ligand-binding chain 
of its receptor, we studied the effect of administration of anti- 
IFN-y mAb  to infected IFN-q,R -/-  mice,  at  the  time  of 
initiation  of infection,  on  the functional  type of CD4 §  T 
cells triggered. Anti-IFN-3, mAb was administered following 
a protocol shown to result in the modulation  of the func- 
tional  phenotype  of CD4 +  T  cells  triggered  in  resistant 
C3H  mice  (7). 
As  shown  in  Fig.  5,  treatment  with  anti-IFN-'y  mAb 
significantly increased both lesion  size  and parasite burden 
of IFN-yR +/§  mice to levels similar to those seen in IFN- 
3'R-/-  mice not  treated  with  antibodies.  Although  there 
was a slight,  not significant,  increase in lesion size in IFN- 
3'R-/-  mice treated with anti-IFN-3, antibodies compared 
with untreated  IFN-yR-/-  controls,  there was no increase 
in parasite  burden. 
Enumeration of IFN-3,-producing cells by ELISPOT showed 
that  anti-IFN-3,  mAb  treatment  of  both  infected  IFN- 
3,R -/-  and  IFN-3,R +/+  mice did not  result  in  a decrease 
in the number  of spleen  or LN cells  capable of producing 
IFN-3, upon specific stimulation in vitro (Fig.  6).  Similarly, 
Northern  blot  analysis  of RNA from  spleen and LN cells 
confirmed those results since no decrease in IFN-3' mRNA 
was observed after treatment of either IFN-'yR-/-  or IFN- 
3,R §  mice with  anti-IFN-y  mAb  (Fig.  7). 
This treatment with anti-IFN-3, mAb did not lead to the 
expansion of IL-4-producing T cells since biologically active 
IL-4 could not be detected in supernatants  of spleen or LN 
cells from infected IFN-q,R-/-  and IFN-q,R +/+  mice after 
specific  stimulation  in vitro.  Northern  blot  analysis  shows 
that  treatment  of either  IFN-q,R-/-  or IFN-'yR +  / + mice 
with  anti-IFN-3,  mAb did not have any effect on the level 
of expression of IL-4 mRNA (data not shown). As the level L~ 
Z 
O2 
Relative  Fluorescence 
IFNT-R+/+ 
Figure 4.  IFN-3"  treatment in vitro does not 
enhance  Ly6A/E expression in IFN-TR -/- 
LN cells. In the experiment  shown, LN cells 
(4  x  106/ml) from  IFN-TR -/-  (left) and 
IFN-TR  +/+  mice (right) were cultured  for 
72 h with (s/taded areas) or without (white areas) 
200 U/ml of recombinant  mouse IFN-7. The 
expression of the Ly6A/E molecule was assayed 
by flow cytometry with the FITC-conjugated 
anti-Ly6A/E D7 mAb as described in Materials 
and Methods.  Identical results were also ob- 
tained when either the IFN-3" concentration 
(50 or 1,000 U/ml) or the cell culture time (24 
or 48 h) was varied. 
of IL-4 mRNA was always extremely low, we used a more 
sensitive  RT-PCP,  method  in  an  attempt  to  detect  IL-4 
mRNA  in  uninfected  and  L.  major-infected  IFN-TR -/- 
and  IFN-TR +/+  mice.  RNA  from  infected BALB/c and 
C57BL/6 mice were used as reference controls. The level of 
IL-4 message in infected IFN-TR-/-  and IFN-3'R +  / + mice 
was  similar  to  that  seen  in  resistant  C57BL/6  mice  and 
significantly lower than  that  observed in BALB/c mice in- 
fected for the same period of time (Fig. 8). Additionally, use 
of this technique confirmed that treatment with anti-IFN-'y 
mAb did not significantly modify the IL-4 mRNA levels in 
infected IFN-TP,-/-  mice. Similarly, it is noteworthy that 
this treatment did not subseguently lead to enhanced levels 
of IL-4 message in IFN-TR +/+  mice. 
Discussion 
The results presented in this report confirm the crucial role 
of IFN-T in the elimination  of L.  major by infected hosts. 
Indeed, macrophages are the only mammalian cells that sup- 
port the growth of these parasites, and IFN-7 has dearly been 
shown to be the main lymphokine that activates macrophages 
to a parasiticidal state (2, 31). The IFN-y-mediated destruc- 
tion of intracellular  L. major  by macrophages has been demon- 
strated,  in the mouse, to depend on the t-arginine-depen- 
dent production of NO by these cells (3, 4). Thus, the severity 
of infection observed in IFN-TR-/-  mice is consistent with 
previous  results  showing  that  macrophages  from  IFN- 
TR -/-  mice did  not  release  nitrites  upon  stimulation  in 
vitro with IFN-7 either in the absence or the presence of 
LPS  (16). 
Understanding of the mechanisms operating in the initia- 
tion of Thl  or Th2 CD4 + T  cell development from naive 
precursors is an important  issue currently under investiga- 
tion in several laboratories. Evidence, derived from in vitro 
and in vivo studies with various antigenic systems, exists for 
an important  role of cytokines present  at the initiation  of 
primary CD4 + T  cell stimulation  on the differentiation of 
naive  CD4 +  T  ceils  toward  one  or  the  other  functional 
phenotype. 
Experimental  infection of mice with L.  major represents 
one of the first and best models of infection in which resis- 
tance and susceptibility were shown to correlate with the ex- 
pansion and result from the activity of functionally distinct 
CD4 + T cell subsets (5, 6). Furthermore, by use of this mu- 
rine  model  of infection,  it  has  also  been  suggested  that 
cytokines present at the initiation  of infection could direct 
the differentiation of CD4 + T call precursors toward one or 
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Figure  5.  Effect of anti-IFN-7 
treatment on the course of L. major 
infection  in IFN-TR +/+ and IFN- 
3,R -/-  mice.  Mice (four  in each 
group) were treated with 2 mg anti- 
IFN-7 mAb 2 d before infection and 
with three additional weekly injec- 
tions of 320/zg mAb. Numbers in 
parentheses indicate the number of 
parasites per lesion as estimated by 
limiting dilution assay. These results 
are from one of two experiments 
with similar results. 
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Figure 6.  Effect  of treatment with anti-IFN-"/mAb  on the number 
of IFN-T-producing cells. Spleen cells of four mice were isolated 40 d 
after infection and stimulated in vitro for 18 h with UV-irradiated para- 
sites. Serial  twofold dilutions were tested in duplicate by ELISPOT to de- 
tect IFN-y-producing  cells. Data presented show the number of IFN- 
v-producing cells per 105 cells and derive from one of two independent 
experiments that gave similar results. 
the other functional phenotype. Although there is a consensus 
that IL-4 and IL-12 play a role in the respective development 
of polarized  Th2  and  Thl  responses  after  infection  with 
L.  major,  the data concerning the role of IFN-y for a  sus- 
Figure 7.  Effect  of  treatment with 
anti-IFN-T mAb on IFN-3~  message 
levels  in mice  40 d after  infection.  Total 
RNA  was  purified from  LN  and 
spleen cells from infected  mice (four 
per  group)  and  was  analyzed by 
Northern blotting for the presence  of 
IFN-"/  messages. A  photo  of the 
ethidium bromide-stained gel (from 
one of  two separate  experiments  with 
similar results) (Etk Br; bottom)  allows 
comparison of relative amounts of 
RNA loaded in each lane. 
Figure 8.  Comparison  of Ib4 message levels by RT-PCR. This is a 
photograph (from one of two separate experiments with similar results) 
of an ethidium bromide-stained gel showing PCR products obtained by 
use of LN cell RNA from various strains of L. major-infected mice 40 d 
after infection. The bands corresponding  to IL-4  and GAPDH are marked. 
tained  expansion  of  Thl-type  CD4 +  T  cells  are  still 
conflicting. 
The observations reported here show that mice lacking the 
ligand-binding chain of the IFN-~/R still mount a polarized 
IFN-'y-producing CD4 + T  cell response without  evidence 
for the expansion of IL-4-producing CD4 + cells,  indicating 
that IFN-3,-mediated signals are not necessary for the differen- 
tiation of CD4 + T  cell precursors toward a Thl phenotype. 
Furthermore the present  results  also indicate that  the lack 
of IFN-7-mediated  signals does not  lead  to the expansion 
of IL-4-producing  CD4 +  T  cells. 
For the first 20 d after infection, both parasite burden and 
IFN-T levels were similar in IFN-TR +  / §  and  IFN-3~R-/- 
mice. However, compared with wild-type mice, significantly 
higher  numbers  of IFN-T-producing  CD4 +  T  cells  were 
observed in  lymphoid tissues  of mice lacking the IFN-~/R 
40 d  after infection.  Since at  this  time the parasite burden 
was considerable in IFN-~/R-/-  mice,  it is likely that  this 
increase in IFN-T production resulted in part from a strong 
and sustained antigenic stimulation. Recent evidence strongly 
indicates that L.  major amastigotes  are able to induce IL-12 
p40 mRNA in macrophages (32). Thus, it is likely that sub- 
stantial amounts of IL-12 are generated as a result of the im- 
portant  number  of amastigotes  in  IFN-TR -/-  mice  and 
could account  for the important  production  of IFN-T ob- 
served in these mice at later stages of infection with L. major, 
since IL-12 has been shown to stimulate IFN-T production 
by T  and NK cells (33). Production of substantial  amounts 
of IL-12 in iFN-TR-/-  mice could also account for the sup- 
pression of an IL-4 response in these mice, since recent results 
have clearly shown that IL-12 strongly suppresses both base 
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cannot completely rule out that a lack of appropriate regula- 
tion of IFN-3r production in mice unable to respond to this 
cytokine could also account, at least in part, for this increased 
production of IFN-3'  observed in  IFN-3,R-/-  mice after 
various stimuli. 
Our results are in line with observations showing that ad- 
ministration of recombinant IFN-3' to infected susceptible 
mice neither allowed the development of sustained Thl-type 
responses  nor inhibited the expansion of Th2 cells (35).  In 
addition, infection ofttALB/c mice with parasites, into which 
the murine IFN-3' gene was introduced and expressed, led 
to the development of severe lesions and did not switch the 
polarized Th2-type response (36). Furthermore, these results 
are in  agreement with  recent results  showing  that  IFN- 
3,R -/-  mice infected with  pseudorabies  virus  develop  a 
Thl-characteristic cytokine response (37). 
In contrast to these results, evidence for a role of IFN-y 
on the differentiation of Thl-type CD4 § T cells in the mu- 
fine model of infection with L. major also exists.  Adminis- 
tration of anti-IFN-3r  mAb at the time of parasite inocula- 
tion not only abrogated the natural resistance of C3H mice 
(2), but also  ablated the Thl-type CD4 + T  cell response 
normally seen in these mice and promoted the development 
of a Th2-type response (7).  NK cells have been shown to 
be the major source of IFN-% produced early during infec- 
tion of mice from some genetically resistant strains,  possibly 
responsible for the expansion of Thl-type CD4 + T  cells 
(38).  Finally,  recent observations made in IFN-y-deficient 
C57BL/6 mice have revealed that these mice, in contrast to 
wild-type control mice, develop  a Th2-type response after 
infection with L. major, without evidence of a Thl-type re- 
sponse  (39). 
The reasons for the difference in the type of CD4 + T cell 
response triggered in IFN-qAk -/-  (this study) and IFN-3' 
knockout mice (39)  after infection with L.  major are not 
known. Although unlikely, it might be argued that, in IFN- 
yR. -/- mice, either IFN-3' could interact with cells through 
a pathway not requiring the ligand-binding chain of the IFN- 
3'R., or that an IFN-y-binding receptor still exists on CD4 + 
T cell precursors in IFN-h'R-/-  mice, thus accounting for 
their differentiation toward the Thl pathway after infection 
with L. major. However, these hypotheses are very unlikely 
since no evidence exists for any residual response to IFN-y 
of cells from IFN-yR-/-  mice. In fact, treatment of cells 
lacking the IFN-'yR ot chain with doses of IFN-qr as high 
as 105 U did not lead to enhanced expression of MHC mol- 
ecules (our unpublished observations).  In addition, results 
presented here show that in vitro treatment of IFN-'yR-/- 
LN cells with IFN-3' does not induce the expression of the 
Ly6A/E molecule (Fig. 4), an IFN-y-inducible surface marker 
(34).  In contrast, such treatment strongly induced the ex- 
pression of this marker on LN cells from wild-type IFN- 
~/R. +  / + mice. Furthermore, early treatment of IFN-3'R-/- 
mice with anti-IFN-3r  mAb failed to result in a switch of 
the CD4 + T  cell response toward the Th2 pathway. Treat- 
ment with anti-IFN-3, mAb was initiated before infection 
with L. major, following a regimen previously shown to re- 
sult in the modulation of the functional phenotype of the 
CD4 + T ceils triggered in resistant  C3H mice, consequently 
reversing their normal resistance to infection (7). This effect 
was critically dependent on the timing of administration of 
anti-IFN-'y mAb, since treatment after infection was unable 
to alter the course of infection (2), strongly suggesting that 
the level of IFN-3' at the initiation of infection was crucial 
in determining whether a Thl or Th2 cytokine pattern sub- 
sequently developed (7).  It is important to emphasize that 
no detectable IFN-'y was produced by either IFN-qrR -/- or 
IFN-3,R +/+  mice at  the  time of infection.  Furthermore, 
even during the early stages of infection, no evidence was 
obtained for the production of larger amounts of IFN-'y in 
IFN-yR -/-  mice. Thus,  it is likely that neutralization of 
IFN-qr by anti-IFN-qr mAb was similar, during the early stages 
of infection, in both  IFN-3,R -/-  and IFN-3,R +/+  mice. 
Taken together, these findings strongly suggest that the Thl- 
type response observed in the present system is not mediated 
by IFN-y. 
The implication of IFN-y in Thl cell development is based 
mainly on observations showing impairment of Thl responses 
in the absence of IFN-qr rather than on experiments demon- 
strating a promotion of sustained expansion of Thl cells by 
exogenous IFN-3'. In the absence of IFN-% the remote pos- 
sibility that other lymphokines could bind to the IFN-qcR 
and transmit signals leading to the differentiation of CD4 + 
T cell precursors towards the Th2 pathway could be consid- 
ered. Although the evidence for the specificity of the binding 
of IFN-y to its receptor is strong, a structural homology be- 
tween the IFN-h'R and the receptor for IL-10 has recently 
been described (40).  Thus, it would be of interest to study 
the differentiations of T  cell subsets  after infection with 
L. major in transgenic mice that lack both the IFN-3, and 
the IFN-3,R genes. Finally,  since the IFN-3, (39) and IFN- 
yR knockout mice (this study) were derived on genetically 
different backgrounds, it is possible that the influence of IFN-y 
on the differentiation of T cell subsets may vary in different 
mouse strains.  Such genetic differences in the importance of 
IFN-y for Thl-type response development could also account 
for the presently reported failure of anti-IFN-3, mAb, ad- 
ministered at the initiation of infection with L. major, to re- 
sult in the differentiation of CD4 + T cell precursors toward 
the Th2 functional pathway, even in resistant wild-type IFN- 
3,R +/+  129/Sv/Ev  mice.  Such treatment has  indeed been 
shown to result in a shift in the T cell response from a Thl- 
to a Th2-type response in resistant C3H/HeN mice infected 
with L.  major (7). 
The importance of IL-12, a cytokine produced by cells with 
accessory or antigen-presenting function (41), for the devel- 
opment of Thl-type CD4 + T  cell responses  after infection 
with L. major, has recently been recognized (42, 43). Although 
the effect of IL-12 on Thl cell development in IFN-3'R-/- 
mice after infection with L. major has not yet been directly 
assessed, the results reported here suggest that such an effect 
of IL-12 would not be dependent on IFN-3,. These data are 
in agreement with other observations showing, on the one 
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with L. major in susceptible mice (35) and, on the other hand, 
the capacity of IL-12 to cure these mice (42). Moreover, in 
other antigenic systems the effect of IL-12 on the differentia- 
tion of Thl-type cells was unaffected by treatment with anti- 
IFN-y antibody (44). Considering this important role of IL- 
12 in Thl cell development, it would be of great interest to 
compare its production after infection with L. major in IFN- 
yR-/-  and IFN-y knockout mice. 
In other antigenic systems, the use of CD4 + T cells ob- 
tained from TCR-ot/B transgenic mice has facilitated  the study 
of the parameters influencing short-term differentiation  of 
CD4 § T  cells after activation by specific antigen in vitro. 
The dominant effect of IL-4 in promoting the development 
of Th2-type responses was clearly demonstrated by observa- 
tions showing that the addition of IL-4 during specific  priming 
of CD4 + T cells from TCR-od/~-transgenic mice inhibited 
the development of Thl-type responses and led to the differen- 
tiation of Th2-type responses (12, 13). Addition of IL-12 
during specific priming of CD4 + T  cells from TCR-ot/ 
B-transgenic mice led to the development of Thl-type re- 
sponses (45, 46). 
In contrast to the well-accepted role of IL-4 and IL-12 on 
the development of Th2 and Thl responses, respectively, the 
data concerning the assessment of the importance of IFN-y 
in promoting the expansion of Thl cells are still unclear. By 
use of differentiated T cell clones, IFN-y has been demon- 
strated to selectively inhibit the proliferation of Th2 cells in 
vitro (30). Using TCR-ot/fl-transgenic mice, some studies 
have shown a requirement for IFN-y in the development of 
CD4 + T cells producing high amounts of IFN-y by use of 
neutralizing antibodies against this cytokine, but have been 
unable  to drive Thl-type cell development by addition of 
IFN-y to the priming cultures (47). In these studies, CD4 § 
T cells from TCR-odB-transgenic mice on a BALB/c back- 
ground were used. The requirement for IFN-y in Thl-type 
T cell development was, however, not shown in other studies 
with CD4 + T cells from other TCR-ot/B-transgenic mice 
on a B10 background, where IFN-y itself did not enhance 
priming for IFN-y production, nor did anti-IFN-3, reduce 
such priming (13). Furthermore, even though evidence for 
an IFN-y dependence of the effect of IL-12 on the develop- 
ment of Thl-type response has been obtained in one TCR- 
cff/5-transgenic system (47), the IL-12-mediated enhancement 
of priming for IFN-y production, also using an accessory 
ceU-dependent antigenic system with CD4 + T  cells from 
other TCR-ot//5-transgenic  mice, was not blocked by anti- 
IFN-y mAb (45). However, in this study, upon stimulation 
of CD4 + T  cells in an accessory cell-independent system, 
the ability of IL-12 to enhance production of IFN-y was sub- 
stantially diminished in the presence of anti-IFN-7 antibodies 
(45).  As CD4 + T  cells from mice with different genetic 
backgrounds were used in these two studies, these results 
could reflect genetic differences in the importance of IFN-y 
in the regulation of  T cell subset differentiation. Furthermore, 
they indicate that the requirements for priming in accessory 
cell-dependent and -independent systems may be different. 
In humans, IL-12 was also recently shown to promote Thl- 
type response in an IFN-y-independent manner (48). 
In conclusion,  the data presented here do not support  a 
critical role for IFN-y in Thl cell development in vivo. They 
are in agreement with observations made in vitro that have 
led to the hypothesis that, in the absence of sufficient amounts 
of IL-4, the development of an IFN-y-producing CD4 + T 
cell response could represent the "default" pathway of differen- 
tiation of CD4 + T cell precursors (13). Thus,  it is possible 
that the concentrations of IL-4 at the site of the developing 
lesion in IFN-yR-/-  mice are not sufficient to either ini- 
tiate priming for IL-4-producing T cell response or inhibit 
the differentiation of IFN-y-producing CD4 + T cells. Our 
results  also underline the importance of mice  genetically 
deficient in critical cytokine receptors  for a better understanding 
of the factors regulating the T  cell response to infectious 
pathogens. 
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